RNA Biology

RNA Biology is an open access international peer-reviewed journal for RNA research including structural biology, genome, transcription, and splicing research. RNA has played a central role in all cellular processes since the beginning of life: decoding the genome, regulating gene expression, structural biology, mediating molecular interactions, and catalyzing chemical reactions. RNA Biology, as a leading journal in the field, provides a platform for presenting and discussing all cutting-edge RNA research. The journal accepts the following types of article: Research Paper/Report, Brief Communications, Technical Paper, Commentaries and Views, Meeting Reports, Letters to the Editor, Reviews, Point-of-View, Commentaries. The journal publishes research related to: RNA biochemistry & structural biology Transcription & translation Regulatory RNAs in eukaryotes and prokaryotes Sequencing & bioinformatics RNA localization RNA in disease and therapy other topics relevant to RNA biology RNA Biology offers a variety of formats for paper submission, including original research articles, short reports, reviews and commentaries. The journal only publishes manuscripts in English. Open Access means you can publish your research so it is free to access online as soon as it is published, meaning anyone can read (and cite) your work. Please see our guide to Open Access for more information. Many funders mandate publishing your research open access; you can check open access funder policies and mandates here. The standard article publishing charge (APC) for this journal is $3,175 / £2,495 / €2,895 / AUD 4,335 plus VAT, or other local taxes where applicable in your country. There is no submission charge. Find out more about article publishing charges and funding options. RNA Biology operates a single anonymized peer review policy. Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print. *Please note that RNA Biology converted to a full Open Access journal from Volume 19 (2022).